We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
+0.55%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$48B
AUM Growth
-$1.59B
Cap. Flow
-$1.46B
Cap. Flow %
-3.05%
Top 10 Hldgs %
24.06%
Holding
1,904
New
84
Increased
534
Reduced
502
Closed
55

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$60.6M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$50.8M
3
MA icon
Mastercard
MA
+$43.1M
4
ADI icon
Analog Devices
ADI
+$40.3M
5
AVGO icon
Broadcom
AVGO
+$40.1M

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$92.3M
2
NVDA icon
NVIDIA
NVDA
+$92.1M
3
LLY icon
Eli Lilly
LLY
+$80.8M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$74.2M
5
MSFT icon
Microsoft
MSFT
+$69.1M

Sector Composition

Rank Sector Weight
1 Technology 24.14%
2 Financials 15.08%
3 Healthcare 14.69%
4 Consumer Discretionary 11.11%
5 Communication Services 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAGE
1451
DELISTED
Sage Therapeutics
SAGE
$956K ﹤0.01%
21,567
-7,745
-26% -$355K
PBI icon
1452
Pitney Bowes
PBI
$2.43B
$955K ﹤0.01%
132,500
CSII
1453
DELISTED
Cardiovascular Systems, Inc.
CSII
$946K ﹤0.01%
28,800
TBI
1454
Trueblue
TBI
$238M
$945K ﹤0.01%
34,903
EGRX
1455
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$944K ﹤0.01%
16,917
TPL icon
1456
Texas Pacific Land
TPL
$27B
$943K ﹤0.01%
+7,020
New +$1.09M
VREX icon
1457
Varex Imaging
VREX
$472M
$942K ﹤0.01%
33,405
BOOM icon
1458
DMC Global
BOOM
$111M
$941K ﹤0.01%
25,500
IDYA icon
1459
IDEAYA Biosciences
IDYA
$3.44B
$941K ﹤0.01%
36,915
AAMI
1460
Acadian Asset Management
AAMI
$2.94B
$941K ﹤0.01%
36,000
PWR icon
1461
Quanta Services
PWR
$87.8B
$928K ﹤0.01%
8,156
-20,574
-72% -$2.06M
TILE icon
1462
Interface
TILE
$2B
$928K ﹤0.01%
61,274
DNA icon
1463
Ginkgo Bioworks
DNA
$498M
$918K ﹤0.01%
+2,013
New +$980K
XLRE icon
1464
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.78B
$916K ﹤0.01%
+20,600
New +$957K
VNDA icon
1465
Vanda Pharmaceuticals
VNDA
$309M
$914K ﹤0.01%
53,300
CRVL icon
1466
CorVel
CRVL
$3.16B
$912K ﹤0.01%
14,700
+900
+7% +$46.9K
MATW icon
1467
Matthews International
MATW
$890M
$912K ﹤0.01%
26,301
TTEC icon
1468
TTEC Holdings
TTEC
$118M
$907K ﹤0.01%
9,700
FND icon
1469
Floor & Decor
FND
$6.17B
$906K ﹤0.01%
7,500
-7,536
-50% -$899K
ADUS icon
1470
Addus HomeCare
ADUS
$2.22B
$893K ﹤0.01%
11,200
PTC icon
1471
PTC
PTC
$14.9B
$891K ﹤0.01%
7,438
-1,782
-19% -$238K
CHEF icon
1472
Chefs' Warehouse
CHEF
$4.12B
$889K ﹤0.01%
27,300
TECH icon
1473
Bio-Techne
TECH
$11.2B
$887K ﹤0.01%
7,316
-129,428
-95% -$15.8M
NTNX icon
1474
Nutanix
NTNX
$16.1B
$883K ﹤0.01%
+23,410
New +$885K
OII icon
1475
Oceaneering
OII
$4.79B
$883K ﹤0.01%
66,300
+45,800
+223% +$597K

Similar funds

Ensign Peak Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Ensign Peak Advisors held 1,904 positions worth $48B, down 3.2% from $49.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Ensign Peak Advisors withdrew a net $1.46B in Q3 2021, closing 55 positions and reducing 502 holdings. Its most notable exit was Root, an estimated $29.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ensign Peak Advisors opened a new position in State Street SPDR S&P Biotech ETF worth $37.7M.

  • Ensign Peak Advisors's largest Q3 2021 buy was State Street SPDR S&P Biotech ETF: 300,000 shares worth $37.7M.
  • Ensign Peak Advisors added most to AbbVie in Q3 2021, an estimated $60.6M increase.
  • Ensign Peak Advisors's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $92.3M.
  • Ensign Peak Advisors fully exited Root in Q3 2021, selling an estimated $29.6M.
  • Ensign Peak Advisors's ten largest holdings make up 24% of its $48B portfolio in Q3 2021.
  • Ensign Peak Advisors opened 84 new positions and closed 55 in Q3 2021.
  • Ensign Peak Advisors's portfolio value fell 3.2% quarter-over-quarter to $48B.

Based on Ensign Peak Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.